Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

Berglind O. Einarsdottir; Joakim Karlsson; Elin M. V. S?derberg; Mattias F. Lindberg; Elisa Funck-Brentano; Henrik Jespersen; Siggeir F. Brynjolfsson; Roger Olofsson Bagge; Louise Carstam; Martin Scobie; Tobias Koolmeister; Olof Wallner; Ulrika Stierner; Ulrika Warpman Berglund; Lars Ny; Lisa M. Nilsson; Erik Larsson; Thomas Helleday; Jonas A. Nilsson

首页> 外文期刊>Cell death & disease. >Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

【24h】

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

机译：校正：患者衍生的异种移植前临床试验揭示了转移性黑色素瘤中karonudib的治疗反应和抗性机制

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

On Pubmed, the name of co-author Roger Olofsson Bagge appeared incorrectly as "Bagge RO" instead of "Olofsson Bagge, Roger". This has been corrected in the PDF and HTML versions.

机译：在PubMed上，共同作者Roger Olofsson Bagge的名称被错误地呈现为“Bagge Ro”而不是“Olofsson Bagge，Roger”。这已在PDF和HTML版本中纠正。

著录项

来源
《Cell death & disease.》 |2020年第2期|共页
作者
Berglind O. Einarsdottir; Joakim Karlsson; Elin M. V. S?derberg; Mattias F. Lindberg; Elisa Funck-Brentano; Henrik Jespersen; Siggeir F. Brynjolfsson; Roger Olofsson Bagge; Louise Carstam; Martin Scobie; Tobias Koolmeister; Olof Wallner; Ulrika Stierner; Ulrika Warpman Berglund; Lars Ny; Lisa M. Nilsson; Erik Larsson; Thomas Helleday; Jonas A. Nilsson;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma [J] . Berglind O. Einarsdottir, Joakim Karlsson, Elin M. V. S?derberg, Cell death & disease. . 2018,第8期

机译：患者衍生的异种移植前临床试验显示治疗反应和转移黑素瘤的karonudib的抗性机制
2. Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer [J] . D. Merino, T. S. Weber, A. Serrano, Nature Communications . 2019,第1期

机译：出版商纠正：条码揭示了患者源性转移性三阴性乳腺癌异种移植物中的复杂克隆行为
3. BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance. [J] . Alcala AM, Flaherty KT Clinical cancer research: an official journal of the American Association for Cancer Research . 2012,第1期

机译：用于治疗转移性黑色素瘤的BRAF抑制剂：临床试验和耐药机制。
4. Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model [C] . Thinzar M. Lwin, Kentaro Miyake, Takashi Murakami, Molecular-Guided Surgery: Molecules, Devices, and Applications IV . 2018

机译：荧光人源化抗CEA抗体在源自患者的原位异种移植（PDOX）小鼠模型中特异性标记转移性胰腺癌
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma [O] . Berglind O. Einarsdottir, Joakim Karlsson, Elin M. V. Söderberg, 2020

机译：更正：一项源自患者的异种移植物临床前试验揭示了转移性黑素瘤的治疗反应和对卡洛地布的耐药机制
7. A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma [O] . Berglind O. Einarsdottir, Joakim Karlsson, Elin M. V. Söderberg, 2018

机译：患者衍生的异种移植前临床试验显示治疗反应和转移黑素瘤的karonudib的抗性机制

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

摘要

著录项

相似文献

相关主题

期刊订阅